Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
07/2012
07/05/2012US20120172427 (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide tablet formulations with improved stability
07/05/2012US20120172399 Compounds as hypoxia mimetics, and composiitons and uses thereof
07/05/2012US20120172396 2-adamantylurea derivatives as selective 11b-hsd1 inhibitors
07/05/2012US20120172385 Ortho substituted pyrimidine compounds as jak inhibitors
07/05/2012US20120172384 Heterocyclylaminopyrimidines as kinase inhibitors
07/05/2012US20120172379 4 substituted pyrazolopyrimidines
07/05/2012US20120172361 Triazine derivatives and their therapeutical applications
07/05/2012US20120172352 Pyrazoline dione derivatives as nadph oxidase inhibitors
07/05/2012US20120172345 Heteroaryls and uses thereof
07/05/2012US20120172286 Therapeutic use for alpha1 proteinase inhibitor in hematopoiesis
07/05/2012US20120172285 Methods and compositions for specific modulation of mcl-1
07/05/2012US20120171302 Compositions and methods for inhibiting redox-sensitive gtpases
07/05/2012US20120171292 Luminescent porous silicon nanoparticles for targeted delivery and immunization
07/05/2012US20120171290 Hpv particles and uses thereof
07/05/2012US20120171289 Delivery systems for bioactive agents
07/05/2012US20120171284 Celecoxib compositions
07/05/2012US20120171275 Local administration of gallium compositions to treat pain
07/05/2012US20120171256 Electrospun silk material systems for wound healing
07/05/2012US20120171251 Sheet-form preparation and method for producing the same
07/05/2012US20120171248 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/05/2012US20120171245 Inhibitors of influenza viruses replication
07/05/2012US20120171244 Mucosal boosting following parenteral priming
07/05/2012US20120171243 Method of preparing live viral vaccines by genetic engineering of viral genome
07/05/2012US20120171242 Modified Antibody
07/05/2012US20120171241 Analysis of saccharide vaccines without interference
07/05/2012US20120171240 Immunostimulatory compositions and methods
07/05/2012US20120171239 Immunogenic Conjugates for Producing Immune Responses to Drugs of Abuse and Methods of Use
07/05/2012US20120171238 S. aureus allergen
07/05/2012US20120171237 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
07/05/2012US20120171235 Markers of xmrv infection and uses thereof
07/05/2012US20120171234 Novel Biologically Active Peptides and their New Uses
07/05/2012US20120171233 Peptide inhibitors for mediating stress responses
07/05/2012US20120171231 Use of nutritional compositions including lactoferrin in stimulating immune cells
07/05/2012US20120171230 Oral vaccines produced and administered using edible micro-organism
07/05/2012US20120171229 Synthetic nanocarriers with reactive groups that release biologically active agents
07/05/2012US20120171212 Therapeutic compositions and methods for the prevention of autoimmune diseases
07/05/2012US20120171211 Serum resistance factors of gram positive bacteria
07/05/2012US20120171208 Anti-PRO87299 Antibodies
07/05/2012US20120171207 Depleting immunosuppressive monocytes within a mammal
07/05/2012US20120171205 Galectin-Immunoglobulin Chimeric Molecules
07/05/2012US20120171204 Compositions and methods for the treatment and diagnosis of immune disorders
07/05/2012US20120171202 Rage Fusion Proteins And Methods Of Use
07/05/2012US20120171199 Tricyclic pi3k inhibitor compounds and methods of use
07/05/2012US20120171198 Use of igg1 immunoglobulins and/or ligands of the cd32 receptor for treating inflammatory diseases and manifestations via the mucosal route
07/05/2012US20120171197 Binding members for interleukin-4 receptor alpha (IL-4Ra) - 173
07/05/2012US20120171195 Anti-hla-e antibodies, therapeutic immunomodulatory antibodies to human hla-e heavy chain, useful as ivig mimetics and methods of their use
07/05/2012US20120171193 Diagnostic and Treatment Methods for Characterizing Bacterial Microbiota in Skin Conditions
07/05/2012US20120171186 method for producing a nutraceutical composition and the nutraceutical produced by the method
07/05/2012US20120171180 Compositions comprising amnion derived adherent cells and platelet-rich plasma
07/05/2012US20120171161 Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
07/05/2012US20120171159 Non-pathogenic and/or attenuated bacteria capable of inducing apoptosis in macrophages, process of manufacturing and uses thereof
07/05/2012US20120171156 Methods and compounds for reducing allergic reactions to hair dyes
07/05/2012US20120171126 NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS COMPOSITIONS AND USES THEREOF
07/05/2012US20120171116 Arginase Inhibitors and Methods of Use Thereof
07/05/2012CA2834402A1 Clostridium difficile antigens
07/05/2012CA2823065A1 Immunostimulatory oligodeoxynucleotides
07/05/2012CA2822924A1 Roadmap for controlling malaria
07/05/2012CA2822664A1 Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
07/05/2012CA2754477A1 Method for screening and purifying enterovirus, method for mass-producing enterovirus, and method for manufacturing enterovirus vaccine
07/04/2012EP2471938A2 Recombinant polyvalent vaccine
07/04/2012EP2471937A2 Recombinant polyvalent vaccine
07/04/2012EP2471936A2 Recombinant polyvalent vaccine
07/04/2012EP2471926A2 Immunostimulatory oligodeoxynucleotides
07/04/2012EP2471818A1 Humanized anti-factor D antibodies and uses thereof
07/04/2012EP2471774A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2471773A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2471546A1 Therapeutic agent for rhinitis
07/04/2012EP2471543A1 Tolerance induction or immunosupression to prevent in particular Graft-versus-Host-Disease (GvHD) by short-term pre-incubation of transplanted cell suspensions, tissues or organs coated with ligands to cell surface molecules
07/04/2012EP2470537A2 Heterocyclic compounds as janus kinase inhibitors
07/04/2012EP2470198A2 Glucagon-like peptide-1 receptor (glp-1r) agonists for treating autoimmune disorders
07/04/2012EP2262799B1 Pyridine compounds
07/04/2012EP2262782B1 Novel aminomethyl benzene derivatives
07/04/2012EP2004649B1 Phenolic hydrazone macrophage migration inhibitory factor inhibitors
07/04/2012EP1550662B1 Adenine compound and use thereof
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012CN202286407U Face mask for preventing and treating allergic asthma
07/04/2012CN1962641B Metalloproteinase inhibitors
07/04/2012CN1918284B Stem cells
07/04/2012CN1907967B Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
07/04/2012CN1882354B 细胞因子调节剂及相关用法 Cytokines regulate agents and related usage
07/04/2012CN102549148A Method of preparing plant-derived vlps
07/04/2012CN102548992A 2, 7 -naphthyridin- 1 -one derivatives as syk kinase inhibitors
07/04/2012CN102548945A Apogossypolone derivatives as anticancer agents
07/04/2012CN102548579A Dosage regimen of an s1p receptor modulator
07/04/2012CN102533588A Lactobacillus brevis for producing extracellular exopolysaccharide and application thereof
07/04/2012CN102532339A Method for selenizing pilose asiabell root polysaccharides and application of product
07/04/2012CN102532337A Method for producing glycyrrhizia polysaccharide by utilizing tissue culture method
07/04/2012CN102532320A Single-chain antibody of fully-human anti-human interleukin-21 receptor and application thereof
07/04/2012CN102532229A Pregnane glycoside compounds with orthoester groups and applications thereof
07/04/2012CN102532144A Novel indoleamine-2,3-dioxygenase inhibitor as well as preparation method and application thereof
07/04/2012CN102532135A Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
07/04/2012CN102532134A Azaindoles useful as inhibitors of janus kinases
07/04/2012CN102532133A Azaindoles useful as inhibitors of janus kinases
07/04/2012CN102532051A 有丝分裂驱动蛋白抑制剂及其使用方法 Mitotic kinesin inhibitors and methods of use
07/04/2012CN102532042A Aryl urea compound as well as intermediate and application thereof
07/04/2012CN102531948A 氨基-甲基取代的四环素类化合物 Amino - methyl-substituted tetracycline compounds
07/04/2012CN102526737A DPP IV inhibitor formulations
07/04/2012CN102526736A Treatment of inflammatory diseases
07/04/2012CN102526732A Application of targeted medicine adjusting histone acetylation level in aspect of preparing medicine for preventing or treating autoimmune disease
07/04/2012CN102526719A Application of influenza vaccine in preparation of medicament for treating allergic diseases and allergy related diseases
1 ... 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 ... 1172